Results
|
|
10101.
|
|
|
|
10102.
|
|
|
|
10103.
|
|
|
|
10104.
|
|
|
|
10105.
|
|
|
|
10106.
|
|
|
|
10107.
|
|
|
|
10108.
|
|
|
|
10109.
|
|
|
|
10110.
|
|
|
|
10111.
|
|
|
|
10112.
|
|
|
|
10113.
|
|
|
|
10114.
|
|
|
|
10115.
|
|
|
|
10116.
|
Quality of reporting of serious adverse drug events to an institutional review board: a case study with the novel cancer agent, imatinib mesylate. [electronic resource] by
- Dorr, David A
- Burdon, Rachel
- West, Dennis P
- Lagman, Jennifer
- Georgopoulos, Christina
- Belknap, Steven M
- McKoy, June M
- Djulbegovic, Benjamin
- Edwards, Beatrice J
- Weitzman, Sigmund A
- Boyle, Simone
- Tallman, Martin S
- Talpaz, Moshe
- Sartor, Oliver
- Bennett, Charles L
Producer: 20090707
In:
Clinical cancer research : an official journal of the American Association for Cancer Research vol. 15
Availability: No items available.
|
|
|
10117.
|
|
|
|
10118.
|
|
|
|
10119.
|
|
|
|
10120.
|
|